发明名称 BIOMARKER FOR PRE-SELECTION OF PATIENT FOR ANTI-IGF1R THERAPY
摘要 <P>PROBLEM TO BE SOLVED: To provide a method to identify specific cancer populations and/or specific cancer patients who are most likely to respond to one or more anti-cancer therapies that target IGF1R. <P>SOLUTION: Methods for identifying patients whose cancers are likely to be responsive to IGF1R inhibitory anti-cancer therapy, along with methods for treating such patients are provided. Patients identified by the method can be treated with any of several known IGF1R inhibitory agents including antibodies, small molecule inhibitors and anti-sense nucleic acids. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012067124(A) 申请公布日期 2012.04.05
申请号 JP20110280276 申请日期 2011.12.21
申请人 SCHERING CORP 发明人 WANG YAN;PACHTER JONATHAN;WANG YAOLIN;LIU MING
分类号 A61K31/352;A61K31/4439;A61K31/519;A61K38/22;A61K39/395;A61P35/00;C07K16/28;C12N15/09 主分类号 A61K31/352
代理机构 代理人
主权项
地址